Literature DB >> 24743905

Surgical strategy for T1 gallbladder cancer: a nationwide multicenter survey in South Korea.

Seung Eun Lee1, Jin-Young Jang, Sun-Whe Kim, Ho-Seong Han, Hong-Jin Kim, Sung-Su Yun, Baik-Hwan Cho, Hee Chul Yu, Woo Jung Lee, Dong-Sup Yoon, Dong Wook Choi, Seong-Ho Choi, Soon-Chan Hong, Sang-Mok Lee, Hyun Jong Kim, In Seok Choi, In-Sang Song, Sang-Jae Park, Sungho Jo.   

Abstract

BACKGROUND: The aim of this study was to investigate the clinical features and clinical outcomes of T1 gallbladder (GB) cancer and to determine an appropriate surgical strategy for T1 GB cancer.
METHODS: A nationwide multicenter study, in which 16 University Hospitals in Korea participated, was performed from 1995 to 2004. A total of 258 patients, 117 patients with T1a and 141 patients with T1b disease were enrolled. Clinicopathologic findings and long-term follow-up results were analyzed after a consensus meeting of the Korean Pancreas Surgery Club was held.
RESULTS: Simple cholecystectomy was performed in 95 patients (81.2 %) with T1a tumor and in 89 patients (63.1 %) with T1b tumor (p < 0.01). Lymph node metastasis was observed in 2.9 % of T1a patients and in 9.9 % of T1b patients (p = 0.391). A significant difference in 5-year disease-specific survival (DSS) rates was observed between T1a and T1b patients (96.4 vs 84.8 %, respectively, p = 0.03). However, no significant 5-year DSS rate difference was observed between those who underwent simple cholecystectomy or extended cholecystectomy, regardless of whether lymph node dissection was performed or whether lymph node metastasis was present. There was no significant difference in recurrence-free survival between simple cholecystectomy and extended cholecystectomy.
CONCLUSIONS: There was no superiority of extended cholecystectomy over simple cholecystectomy in the aspect of survival and recurrence especially in T1b gallbladder cancer. Furthermore, the effectiveness of regional lymphadenectomy for treatment purpose remains questionable. Therefore, simple cholecystectomy could be recommended as a surgical strategy of T1 gallbladder cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24743905     DOI: 10.1245/s10434-014-3527-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  12 in total

1.  Prognostic Impact of Lymph Node Excision in T1 and T2 Gallbladder Cancer: a Population-Based and Propensity Score-Matched SEER Analysis.

Authors:  Thomas Steffen; Sabrina M Ebinger; Ignazio Tarantino; Bernhard Widmann
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

2.  Diagnostic performance and inter-observer variability to differentiate between T1- and T2-stage gallbladder cancers using multi-detector row CT.

Authors:  Yong Jae Kwon; Kyoung Doo Song; Seong Eun Ko; Jeong Ah Hwang; Minji Kim
Journal:  Abdom Radiol (NY)       Date:  2022-02-22

3.  Impact of Type of Surgery on Survival Outcome in Patients With Early Gallbladder Cancer in the Era of Minimally Invasive Surgery: Oncologic Safety of Laparoscopic Surgery.

Authors:  Jin-Young Jang; Jin Seok Heo; Youngmin Han; Jihoon Chang; Jae Ri Kim; Hongbeom Kim; Wooil Kwon; Sun-Whe Kim; Seong Ho Choi; Dong Wook Choi; Kyoungbun Lee; Kee-Taek Jang; Sung-Sik Han; Sang-Jae Park
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

4.  Prognostic significance of regional lymphadenectomy in T1b gallbladder cancer: Results from 24 hospitals in China.

Authors:  Tai Ren; Yong-Sheng Li; Xue-Yi Dang; Yang Li; Zi-Yu Shao; Run-Fa Bao; Yi-Jun Shu; Xu-An Wang; Wen-Guang Wu; Xiang-Song Wu; Mao-Lan Li; Hong Cao; Kun-Hua Wang; Hong-Yu Cai; Chong Jin; Hui-Han Jin; Bo Yang; Xiao-Qing Jiang; Jian-Feng Gu; Yun-Fu Cui; Zai-Yang Zhang; Chun-Fu Zhu; Bei Sun; Chao-Liu Dai; Lin-Hui Zheng; Jing-Yu Cao; Zhe-Wei Fei; Chang-Jun Liu; Bing Li; Jun Liu; Ye-Ben Qian; Yi Wang; Ya-Wei Hua; Xi Zhang; Chang Liu; Wan-Yee Lau; Ying-Bin Liu
Journal:  World J Gastrointest Surg       Date:  2021-02-27

5.  Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model.

Authors:  Kisyo Mihara; Sachiko Matsuda; Yuki Nakamura; Koichi Aiura; Akihiro Kuwahata; Shinichi Chikaki; Masaki Sekino; Moriaki Kusakabe; Shunichi Suzuki; Daiichiro Fuchimoto; Akira Onishi; Junko Kuramoto; Kaori Kameyama; Osamu Itano; Hiroshi Yagi; Yuta Abe; Minoru Kitago; Masahiro Shinoda; Yuko Kitagawa
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

Review 6.  Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients.

Authors:  Patricia García; Angela Lamarca; Javier Díaz; Enrique Carrera; Juan Carlos Roa
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

7.  Surgical outcome and prognostic factors in patients with gallbladder carcinoma.

Authors:  Eun Kyung Hong; Kun Kuk Kim; Jung Nam Lee; Woon Kee Lee; Min Chung; Yeon Suk Kim; Yeon Ho Park
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-11-30

8.  Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013).

Authors:  Li Xu; Haidong Tan; Xiaolei Liu; Jia Huang; Liguo Liu; Shuang Si; Yongliang Sun; Wenying Zhou; Zhiying Yang
Journal:  Cancer Med       Date:  2020-03-31       Impact factor: 4.452

9.  The appropriate surgical strategy for T1b gallbladder cancer incidentally diagnosed after a simple cholecystectomy.

Authors:  Byoung-Hyoung Kim; Seok-Hwan Kim; In-Sang Song; Gwang-Sik Chun
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-11-29

10.  Laparoscopic surgery for oncologic extended resection of T1b and T2 incidental gallbladder carcinoma at a high-volume center: a single-center experience in China.

Authors:  Parbatraj Regmi; Hai-Jie Hu; Yin Chang-Hao; Fei Liu; Wen-Jie Ma; Cong-Dun Ran; Jun-Ke Wang; Aliza Paudyal; Nan-Sheng Cheng; Fu-Yu Li
Journal:  Surg Endosc       Date:  2020-11-10       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.